Nextensa NV/SA (EBR:NEXTA)
Belgium flag Belgium · Delayed Price · Currency is EUR
42.30
+0.20 (0.48%)
Aug 13, 2025, 1:12 PM CET

Revance Therapeutics Market Cap

Nextensa NV/SA has a market cap or net worth of €425.47 million as of August 13, 2025. Its market cap has increased by 2.06% in one year.

Market Cap
425.47M
Enterprise Value
1.19B
Revenue
125.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
$42.30

Market Cap Chart

Since September 11, 2000, Nextensa NV/SA's market cap has increased from 121.71M to 425.47M, an increase of 249.57%. That is a compound annual growth rate of 5.15%.

History

DateMarket Cap% Change
Aug 12, 2025425.47M-1.75%
Dec 31, 2024433.05M-10.79%
Dec 29, 2023485.43M-5.88%
Dec 30, 2022515.74M-33.67%
Dec 31, 2021777.57M68.64%
Dec 31, 2020461.09M-31.15%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition